High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease.
High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease.
复制标题
DOI:
10.1186/1471-2377-11-120
复制
发表时间:
2011-10-04
期刊:
影响因子:
2.6
通讯作者:
Nishida N
中科院分区:
文献类型:
--
作者:
Matsui Y;Satoh K;Miyazaki T;Shirabe S;Atarashi R;Mutsukura K;Satoh A;Kataoka Y;Nishida N
The gamma-isoform of the 14-3-3 protein (14-3-3 gamma) is expressed in neurons, and could be a specific marker for neuronal damage. This protein has been reported as a detectable biomarker, especially in the cerebrospinal fluid (CSF) of Creutzfeldt-Jakob disease (CJD) patients by Western blotting (WB) or enzyme-linked immunosorbent assays (ELISAs). Western blotting for 14-3-3 gamma is not sensitive, and the reported data are conflicting among publications. An ELISA specific for 14-3-3 gamma is not available. CJD patients (n = 114 sporadic CJD patients, 7 genetic CJD, and 3 iatrogenic CJD) and 99 patients with other neurodegenerative diseases were examined in this study. The CSF samples obtained were analyzed by Western blotting for 14-3-3 gamma, and by ELISA for total tau protein. We evaluated the sensitivity and specificity of the newly developed sandwich ELISA for 14-3-3 gamma. The cut-off value of the 14-3-3 gamma ELISA was > 1, 683 AU/ml; and sensitivity was 95.2%, with 72.7% specificity. This specificity was the same for the total tau protein ELISA. Seven CJD cases were negative by WB but positive using the 14-3-3 gamma ELISA, indicating that the ELISA is more sensitive. All 21 cases of early stage CJD could be diagnosed using a combination of the 14-3-3γ ELISA and diffusion weighted MR imaging (DWI-MRI). The 14-3-3 gamma ELISA was more sensitive than conventional WB, and was useful for laboratory diagnosis of CJD, similar to the ELISA for the tau protein. Using DWI-MRI and these ELISA tests on CSF, diagnosis of CJD will be possible even at early stages of the disease.
登录
查看更多内容
影响因子:
158.5
作者:
Hsich, G;Kinney, K;Harrington, MG
通讯作者:
Harrington, MG
影响因子:
2.4
作者:
Satoh, Katsuya;Shirabe, Susumu;Eguchi, Katsumi
通讯作者:
Eguchi, Katsumi
影响因子:
9.9
作者:
Sanchez-Juan, P.;Green, A.;Zerr, I.
通讯作者:
Zerr, I.
影响因子:
9.9
作者:
Brandel, JP;Delasnerie-Lauprêtre, N;Alpérovitch, A
通讯作者:
Alpérovitch, A
影响因子:
4.2
作者:
Gmitterova, K.;Heinemann, U.;Zerr, I.
通讯作者:
Zerr, I.